Antibodies

11 Jan 2010 Trubion Pharmaceuticals, Inc. Announces Initiation of a Phase 2 Study of SBI-087 for the Treatment of Rheumatoid Arthritis (RA)
11 Jan 2010 Symphogen Publishes Pre-Clinical Data in Cancer Research Demonstrating Superior Efficacy of Anti-EGFR Monoclonal Antibody Combination Sym004
11 Jan 2010 AnaptysBio Announces Agreement with Roche to Develop Novel Antibodies
11 Jan 2010 Facet Biotech Announces Enrollment of First Patient in Phase 2 Study of Elotuzumab in Patients With Relapsed Multiple Myeloma
11 Jan 2010 Sorrento Therapeutics Announces Antibody Discovery and Development Alliance for the Prevention and Treatment of MRSA Infections
11 Jan 2010 ABLYNX SUCCESSFULLY GENERATES NANOBODIES AGAINST AN ION CHANNEL AND ANNOUNCES NEW GPCR PROGRAMME
11 Jan 2010 Sanofi Pasteur Partners with KaloBios on Novel Biologic for the Prevention and Treatment of Pseudomonas aeruginosa Infections
07 Jan 2010 Pfizer and Debiopharm collaborate to co-develop investigational compound tremelimumab (CP-675,206) in advanced melanoma
07 Jan 2010 Prolias Announces Strategic Technology Acquisition for Human Therapeutic Antibodies
07 Jan 2010 Tolerx Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab
06 Jan 2010 InNexus Biotechnology Develops New Psoriasis Product Based on Its Skin Permeating Antibody Technology
04 Jan 2010 First Patient treated in BioInvent's Phase I Study of the Drug Candidate BI-505 to Treat Multiple Myeloma
04 Jan 2010 NeoPharm Announces IND Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis
29 Dec 2009 Pfizer Discontinues A Phase 3 Trial Of Figitumumab In Non-Small Cell Lung Cancer (NSCLC) For Futility
24 Dec 2009 MedImmune Replies to FDA Complete Response Letter on Motavizumab
22 Dec 2009 PDL BioPharma Announces New Licensing Agreement With Eli Lilly
22 Dec 2009 ABLYNX DEMONSTRATES PROOF-OF-CONCEPT BY BIOMARKER FOR ITS ANTI-THROMBOTIC ALX-0081
22 Dec 2009 Genentech Submits Supplemental Application to FDA for Lucentis in Patients with Retinal Vein Occlusion
22 Dec 2009 to-BBB and Lundbeck to join forces on brain delivery of antibodies for CNS diseases
21 Dec 2009 UCB announces initial clinical trial results involving patients taking certolizumab pegol for moderate to severe Crohn's disease
21 Dec 2009 Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with GlaxoSmithKline
18 Dec 2009 Amgen Receives CHMP Positive Opinion for Prolia(TM) (Denosumab) in the European Union
18 Dec 2009 Cangene receives a positive opinion from the European Medicines Agency ("EMA") for Hepatitis B product
18 Dec 2009 Thallion Announces Letter of Intent with LFB Biotechnologies to Develop and Commercialize Shigamabs®
18 Dec 2009 Herceptin receives positive opinion in record time for the treatment of HER2-positive advanced stomach cancer in Europe

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top